← Oncology Approval Tracker

FDA DECISION ·

Thiotepa (Tepadina first generic)

thiotepa · MSN Laboratories

First generic approvalFirst genericBreast, ovarian and bladder cancers; malignant effusions
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic Tepadina for breast or ovarian adenocarcinoma, malignant intracavitary effusions, and superficial papillary bladder carcinoma.

LAMPGEN ANALYSIS

Why it matters

Added a generic source for several established uses of injectable thiotepa.

What research teams should watch

Tie preparation checks to the intended route and hazardous-drug precautions.

PRIMARY RECORDS

Sources